SBRA

+ Watchlist + Portfolio

Sabra Health Care REIT, Inc.

Recurring revenue Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Fundamentals are temporarily unavailable for SBRA.

SBRA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$624.81M	$647.51M	$703.24M	$774.63M
Cost of Revenue	$162.61M	$195.25M	$227.09M	$271.11M
Gross Profit	$462.20M	$452.27M	$476.15M	$503.53M
Selling, General & Admin	$39.57M	$47.47M	$50.07M	$53.71M
Operating Expenses	$227.36M	$230.56M	$219.69M	$239.66M
Operating Income	$234.84M	$221.71M	$256.46M	$263.87M
EBITDA	$216.89M	$311.81M	$412.61M	$456.83M
Pretax Income	-$76.36M	$15.76M	$127.72M	$157.35M
Income Tax	$1.24M	$2.00M	$1.00M	$1.84M
Net Income	-$77.61M	$13.76M	$126.71M	$155.61M
Diluted EPS	-0.34	0.06	0.54	0.64
Diluted Shares	230.95M	232.79M	236.05M	244.50M

SBRA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$49.31M	$41.28M	$60.47M	$71.54M
Receivables	$147.91M	$133.81M	$131.75M	$111.29M
Current Assets	$201.84M	$180.53M	$198.09M	$189.43M
Total Assets	$5.75B	$5.39B	$5.30B	$5.49B
Current Liabilities	$339.24M	$231.41M	$224.45M	$336.91M
Long-Term Debt	$2.31B	$2.32B	$2.31B	$2.31B
Total Debt	$2.55B	$2.45B	$2.44B	$2.55B
Total Liabilities	$2.69B	$2.58B	$2.56B	$2.67B
Retained Earnings	-$1.45B	-$1.72B	-$1.87B	-$2.01B
Shareholders' Equity	$3.06B	$2.80B	$2.74B	$2.82B
Working Capital	-$137.40M	-$50.88M	-$26.36M	-$147.48M
Net Debt	$2.46B	$2.37B	$2.36B	$2.46B

SBRA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$315.73M	$300.57M	$310.54M	$348.61M
Free Cash Flow	$315.73M	$300.57M	$310.54M	$348.61M
Depreciation & Amortisation	$187.78M	$183.09M	$169.62M	$187.00M
Stock-Based Compensation	$7.45M	$7.92M	$8.99M	$11.36M
Investing Cash Flow	-$216.25M	$103.13M	-$109.00M	-$377.96M
Financing Cash Flow	-$161.71M	-$410.30M	-$181.56M	$40.76M
Dividends Paid	-$277.16M	-$277.45M	-$280.15M	-$289.50M
Share Repurchases	-$4.81M	-$2.68M	—	—
Net Change in Cash	-$62.22M	-$6.60M	$19.98M	$11.41M

SBRA Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$183.54M	$189.15M	$190.04M	$211.90M	$221.75M	$235.87M
Cost of Revenue	$59.93M	$61.10M	$69.65M	$80.42M	$85.64M	$92.27M
Gross Profit	$123.61M	$128.05M	$120.38M	$131.49M	$136.11M	$143.59M
Selling, General & Admin	$12.73M	$12.51M	$12.56M	$15.91M	$14.86M	$16.82M
Operating Expenses	$56.22M	$56.10M	$60.83M	$66.91M	$67.78M	$175.64M
Operating Income	$67.39M	$71.95M	$59.55M	$64.58M	$68.33M	-$32.05M
EBITDA	$111.31M	$137.17M	$100.36M	$107.98M	$122.88M	$61.59M
Pretax Income	$40.72M	$66.04M	$22.95M	$27.64M	$41.34M	-$24.57M
Income Tax	$413.00K	$497.00K	$436.00K	$491.00K	$526.00K	$678.00K
Net Income	$40.30M	$65.54M	$22.54M	$27.23M	$40.88M	-$25.20M
Diluted EPS	0.17	0.27	0.09	0.11	0.16	-0.10
Diluted Shares	240.30M	240.93M	243.56M	252.77M	255.97M	252.27M

SBRA Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$22.65M	$95.17M	$200.60M	$71.54M	$116.53M	$231.58M
Receivables	$126.38M	$155.03M	$113.22M	$111.29M	$148.09M	$130.09M
Current Assets	$155.28M	$256.68M	$320.74M	$189.43M	$271.54M	$368.44M
Total Assets	$5.23B	$5.33B	$5.56B	$5.49B	$5.59B	$5.51B
Current Liabilities	$112.07M	$113.06M	$124.04M	$336.91M	$472.93M	$432.43M
Long-Term Debt	$2.39B	$2.48B	$2.59B	$2.31B	$2.31B	$2.31B
Total Debt	$2.42B	$2.50B	$2.61B	$2.55B	$2.69B	$2.65B
Total Liabilities	$2.53B	$2.62B	$2.74B	$2.67B	$2.80B	$2.76B
Retained Earnings	-$1.91B	-$1.91B	-$1.96B	-$2.01B	-$2.05B	-$2.15B
Shareholders' Equity	$2.70B	$2.71B	$2.82B	$2.82B	$2.79B	$2.75B
Working Capital	$43.21M	$143.62M	$196.70M	-$147.48M	-$201.39M	-$63.99M
Net Debt	$2.37B	$2.38B	$2.39B	$2.46B	$2.55B	$2.39B

SBRA Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$80.26M	$80.96M	$99.96M	$87.43M	$98.36M	$85.82M
Free Cash Flow	$80.26M	$80.96M	$99.96M	$87.43M	$98.36M	$85.82M
Depreciation & Amortisation	$43.49M	$43.59M	$48.51M	$51.41M	$53.13M	$56.38M
Stock-Based Compensation	$2.71M	$2.70M	$2.88M	$3.07M	$3.10M	$4.09M
Investing Cash Flow	-$16.44M	-$45.13M	-$199.84M	-$116.55M	-$105.09M	$86.50M
Financing Cash Flow	-$101.24M	$36.73M	$206.17M	-$100.89M	$52.10M	-$57.36M
Dividends Paid	-$71.37M	-$71.38M	-$71.94M	-$74.81M	-$75.66M	-$75.66M
Share Repurchases	-$5.39M	—	—	—	-$8.25M	—
Net Change in Cash	-$37.42M	$72.55M	$106.30M	-$130.01M	$45.37M	$114.96M

Market Snapshot

About

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in healthcare-related properties. The company focuses on skilled nursing facilities, senior housing, and specialty hospitals across the United States. Sabra generates revenue through triple-net leases and operating leases with healthcare operators.